Quest Diagnostics ( DGX) said it would sell $900 million worth of senior notes in a private placement to complete its acquisition of LabOne ( LABS).

The Lyndhurst, N.J., lab company said the notes will be guaranteed on a senior, unsecured basis by its domestic clinical laboratories. The company has agreed to exchange these private notes for publicly tradable notes having substantially identical terms, and will file a registration statement with the Securities and Exchange Commission. The company expects the offering will be completed by Oct. 31.

On Tuesday, Quest fell 13 cents to $46.55 and LabOne was flat at $43.85.

If you liked this article you might like

Spain to Play Netherlands for World Cup

Spain to Play Netherlands for World Cup

Wal-Mart: Analysts' Upgrades, Downgrades

Wal-Mart: Analysts' Upgrades, Downgrades

Netherlands Advances to World Cup Final

Netherlands Advances to World Cup Final

Apple: Analysts' Upgrades, Downgrades

Apple: Analysts' Upgrades, Downgrades

World Markets Mostly Lower Monday

World Markets Mostly Lower Monday